Regístrese
Buscar en
Medicina Clínica (English Edition)
Toda la web
Inicio Medicina Clínica (English Edition) Reclassification by applying the Framingham equation 30 years to subjects with i...
Journal Information
Vol. 153. Issue 9.
Pages 351-356 (November 2019)
Share
Share
Download PDF
More article options
ePub
Visits
0
Vol. 153. Issue 9.
Pages 351-356 (November 2019)
Original article
DOI: 10.1016/j.medcle.2019.01.035
Reclassification by applying the Framingham equation 30 years to subjects with intermediate cardiovascular risk. MARK study
Reclasificación utilizando la ecuación de Framingham a 30 años a sujetos con riesgo cardiovascular intermedio. Estudio MARK
Visits
0
Leticia Gomez-Sancheza,b, Manuel A. Gomez-Marcosa,b,c,
Corresponding author
magomez@usal.es

Corresponding author.
, Maria C. Patino-Alonsoa,b,d, Jose I. Recio-Rodrigueza,b,e, Marta Gomez-Sancheza, Jesús González-Sáncheza,f, Rosario Alonso-Domíngueza,g, Natalia Sánchez-Aguaderoa,g, Jose A. Maderuelo-Fernandeza,b, Rafel Ramosh,i, Luis Garcia-Ortiza,j, Emiliano Rodriguez-Sancheza,b,c, MARK Group k
a Institute of Biomedical Research of Salamanca (IBSAL), Primary Health Care Research Unit, La Alamedilla Health Center, Salamanca, Spain
b Health Service of Castilla y León (SACyL), Salamanca, Spain
c Department of Medicine, University of Salamanca, Salamanca, Spain
d Department of Statistics, University of Salamanca, Salamanca, Spain
e Faculty of Health Sciences, University of Burgos, Spain
f Department of Nursing, University of Extremadura, Plasencia, Cáceres, Spain
g Department of Nursing and Physical Therapy, University of Salamanca, Salamanca, Spain
h Girona Research Unit, Primary Care Research Institute Jordi Gol (IDIAP Jordi Gol), Biomedical Research Institute of Girona Dr. Josep Trueta (IDBGI), Girona, Spain
i Department of Medical Sciences, University of Girona, Girona, Spain
j Department of Biomedical Sciences and Diagnosis, University of Salamanca, Salamanca, Spain
k redIAPP: Research Network in Preventive Activities and Health Promotion, Spain
This item has received
0
Visits
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (2)
Tables (2)
Table 1. General characteristics of the analyzed subjects.
Table 2. Reclassification of cardiovascular risk with the two FS30 models by age group and sex.
Show moreShow less
Abstract
Background and objective

The estimation of cardiovascular risk (CVR) with scores at 30 years old has a special interest in reclassifying in a suitable way <60 year subjects with intermediate CVR. This study analyzes what percentage of patients with intermediate CVR included in the MARK study is reclassified by applying the 30-year Framingham score (FS30). It also analyzes the degree of agreement between the two equations to classify high risk subjects.

Patients and methods

Cross-sectional study of 966 subjects included in the MARK study. The CVR was calculated with the two versions of the FS30 (based on lipids and body mass index) for “hard” cardiovascular events in subjects with intermediate CVR.

Results

The 59% and 61% of the subjects with intermediate CVR would be classified as if they had high CVR to undergo a hard event if we used the FS30 in both versions. 70% of men and 35% of women would be classified as high CVR (p<0.01). The agreement percentage, measured with the Kappa index, between the equations FS30L and FS30BMI to classify the high-risk subjects was 67.9% (in men 67.4% and in women 68.7%).

Conclusions

In subjects with intermediate CVR the FS30 reclassifies more than the half as high RCV, 2 out of 3 men and 1 out of 3 women.

Keywords:
Cardiovascular risk
30-year Framingham
Primary care
General practice
Prevention
Risk assessment
Abbreviations:
cHDL
cLDL
RCV
SF30
SF30L
SF30IMC
Resumen
Antecedentes y objetivo

La estimación del riesgo cardiovascular (RCV) con ecuaciones a 30 años tienen un interés especial para reclasificar de manera adecuada los sujetos de 60 años con RCV intermedio. Este estudio analiza qué porcentaje de pacientes con RCV intermedio incluido en el estudio MARK se reclasifica aplicando la puntuación de Framingham a 30 años (FS30) y grado de concordancia entre las 2 ecuaciones para clasificar a los sujetos de riesgo alto.

Pacientes y métodos

Estudio transversal de 966 sujetos incluidos en el estudio MARK. El RCV se calculó con las 2 versiones del FS30 (basado en los lípidos y el índice de masa corporal) para eventos cardiovasculares «duros» en sujetos con RCV intermedio.

Resultados

El 59 y el 61% de los sujetos con RCV intermedio se clasificarían como si tuvieran un RCV alto para sufrir un evento difícil si utilizáramos el FS30 en ambas versiones. El 70% de los varones y el 35% de las mujeres se clasificarían como RCV alto (p<0,01). El porcentaje de concordancia, medido con el índice Kappa, entre las ecuaciones FS30L y FS30BMI para clasificar a los sujetos de alto riesgo fue del 67,9% (en varones 67,4% y en mujeres 68,7%).

Conclusiones

En sujetos con RCV intermedio, el FS30 reclasifica más de la mitad como RCV alto, 2 de cada 3 varones y una de cada 3 mujeres.

Palabras clave:
Riesgo cardiovascular
Framingham de 30 años
Atención primaria
Práctica general
Prevención
Evaluación de riesgos

Article

These are the options to access the full texts of the publication Medicina Clínica (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Medicina Clínica (English Edition)

Comprar
Comprar acceso al artículo

Comprando el artículo el PDF del mismo podrá ser descargado

Precio 22,50 €

Comprar ahora
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
Tools
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

es en pt
Política de cookies Cookies policy Política de cookies
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.